B6;129-Ahrtm1Bra Tg(EEF1A1-Ahr*)1Pjvt/Kctt

Status

Available to order

EMMA IDEM:04604
Citation informationRRID:IMSR_EM:04604 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;129-Ahrtm1Bra Tg(EEF1A1-Ahr*)1Pjvt/Kctt
Alternative nameC57BL/6-Tg INS-rat AH receptor
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolAhrtm1Bra, Tg(EEF1A1-Ahr*)1Pjvt
Gene/Transgene symbolAhr, Tg(EEF1A1-Ahr*)1Pjvt

Information from provider

ProviderRaimo Pohjanvirta
Provider affiliationUniversity of Helsinki
Genetic informationThe insertion variant of rat Ahr gene was transferred into C57BL/6JOlaHsd by microinjection. Construct positive offspring were mated with Ahr-null mice to get rid of innate mouse Ahr.
Phenotypic informationHigh resistance to the acute toxicity of dioxins, while sensitivity to induction of drug-metabolizing enzymes by dioxins is retained.
Breeding historyConstruct positive offspring were mated with Ahr-null mice derived from the C57BL/6J strain to get rid of innate mouse Ahr. The Ahr-null mice are also currently used with transgenic construct-positive, mouse AhR-negative mice in breeding the line, as breeding homozygous animals together has in some cases resulted in increased lethality of progeny.
References
  • Transgenic mouse lines expressing rat AH receptor variants--a new animal model for research on AH receptor function and dioxin toxicity mechanisms.;Pohjanvirta Raimo, ;2009;Toxicology and applied pharmacology;236;166-82; 19371626
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreKarolinska Institutet, Stockholm, Sweden

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • lung inflammation / MGI
  • increased susceptibility to bacterial infection / MGI
  • abnormal macrophage physiology / MGI
  • abnormal ovary physiology / MGI
  • pulmonary edema / MGI
  • increased susceptibility to injury / MGI
  • abnormal enzyme/coenzyme activity / MGI
  • abnormal cytokine level / MGI
  • abnormal chemokine level / MGI
  • abnormal interleukin level / MGI
  • abnormal tumor necrosis factor level / MGI
  • increased physiological sensitivity to xenobiotic / MGI
  • abnormal primordial ovarian follicle morphology / MGI
  • pulmonary alveolar edema / MGI
  • abnormal kidney blood vessel morphology / MGI
  • abnormal hepatocyte morphology / MGI
  • small prostate gland anterior lobe / MGI
  • increased body weight / MGI
  • abnormal blood vessel morphology / MGI
  • decreased liver weight / MGI
  • patent ductus venosus / MGI
  • decreased seminal vesicle weight / MGI
  • abnormal circulating hormone level / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • abnormal liver sinusoid morphology / MGI
  • small prostate gland dorsolateral lobe / MGI
  • persistent hyaloid artery / MGI
  • extramedullary hematopoiesis / MGI
  • small liver / MGI
  • pale liver / MGI
  • enlarged spleen / MGI
  • decreased body weight / MGI
  • postnatal growth retardation / MGI
  • hepatic steatosis / MGI
  • abnormal cytokine secretion / MGI
  • abnormal keratinocyte physiology / MGI
  • liver hyperplasia / MGI
  • abnormal Langerhans cell physiology / MGI
  • decreased susceptibility to type IV hypersensitivity reaction / MGI
  • abnormal Langerhans cell morphology / MGI
  • decreased spleen germinal center size / MGI
  • abnormal branching of the mammary ductal tree / MGI
  • small ovary / MGI
  • abnormal ovarian folliculogenesis / MGI
  • abnormal ovulation / MGI
  • decreased germ cell number / MGI
  • decreased corpora lutea number / MGI
  • decreased ovary weight / MGI
  • abnormal superovulation / MGI
MGI phenotypes (gene matching)
  • extramedullary hematopoiesis / MGI
  • abnormal heart morphology / MGI
  • enlarged heart / MGI
  • abnormal coat/ hair morphology / MGI
  • folliculitis / MGI
  • abnormal hair follicle morphology / MGI
  • abnormal auchene hair morphology / MGI
  • alopecia / MGI
  • rectal prolapse / MGI
  • abnormal colon morphology / MGI
  • abnormal kidney blood vessel morphology / MGI
  • abnormal urinary bladder morphology / MGI
  • abnormal urinary bladder urothelium morphology / MGI
  • abnormal liver morphology / MGI
  • small liver / MGI
  • pale liver / MGI
  • abnormal hepatocyte morphology / MGI
  • abnormal liver physiology / MGI
  • abnormal branching of the mammary ductal tree / MGI
  • small prostate gland anterior lobe / MGI
  • abnormal spleen morphology / MGI
  • enlarged spleen / MGI
  • small spleen / MGI
  • spleen hypoplasia / MGI
  • abnormal uterus morphology / MGI
  • small ovary / MGI
  • abnormal ovarian folliculogenesis / MGI
  • seminiferous tubule degeneration / MGI
  • abnormal skin condition / MGI
  • scaly skin / MGI
  • thick skin / MGI
  • spontaneous skin ulceration / MGI
  • skin lesions / MGI
  • abnormal epidermal layer morphology / MGI
  • increased body weight / MGI
  • decreased body weight / MGI
  • weight loss / MGI
  • disorganized retinal layers / MGI
  • abnormal blood vessel morphology / MGI
  • chronic diarrhea / MGI
  • postnatal growth retardation / MGI
  • abnormal immune system physiology / MGI
  • increased inflammatory response / MGI
  • heart inflammation / MGI
  • abnormal atrial thrombosis / MGI
  • lung inflammation / MGI
  • acanthosis / MGI
  • reduced female fertility / MGI
  • abnormal ovulation / MGI
  • decreased litter size / MGI
  • premature death / MGI
  • decreased germ cell number / MGI
  • abnormal spleen red pulp morphology / MGI
  • increased susceptibility to bacterial infection / MGI
  • abnormal macrophage physiology / MGI
  • hepatic steatosis / MGI
  • abnormal cauda epididymis morphology / MGI
  • decreased corpora lutea number / MGI
  • colitis / MGI
  • increased heart weight / MGI
  • vascular smooth muscle hypertrophy / MGI
  • abnormal cytokine secretion / MGI
  • no phenotypic analysis / MGI
  • cardiac fibrosis / MGI
  • bile duct inflammation / MGI
  • gastric polyps / MGI
  • increased liver adenoma incidence / MGI
  • liver fibrosis / MGI
  • decreased liver weight / MGI
  • abnormal keratinocyte physiology / MGI
  • abnormal ovary physiology / MGI
  • nervous system phenotype / MGI
  • abnormal hair shaft morphology / MGI
  • pulmonary edema / MGI
  • patent ductus venosus / MGI
  • abnormal coronary artery morphology / MGI
  • abnormal spermiation / MGI
  • increased incidence of tumors by chemical induction / MGI
  • decreased testis weight / MGI
  • decreased ovary weight / MGI
  • decreased seminal vesicle weight / MGI
  • decreased epididymis weight / MGI
  • increased spleen weight / MGI
  • abnormal thrombosis / MGI
  • liver hyperplasia / MGI
  • increased susceptibility to injury / MGI
  • abnormal Langerhans cell physiology / MGI
  • renal/urinary system phenotype / MGI
  • homeostasis/metabolism phenotype / MGI
  • reproductive system phenotype / MGI
  • skeleton phenotype / MGI
  • abnormal circulating hormone level / MGI
  • teratozoospermia / MGI
  • abnormal enzyme/coenzyme activity / MGI
  • decreased susceptibility to type IV hypersensitivity reaction / MGI
  • abnormal Langerhans cell morphology / MGI
  • abnormal male germ cell apoptosis / MGI
  • decreased spleen white pulp amount / MGI
  • decreased spleen germinal center size / MGI
  • abnormal cytokine level / MGI
  • abnormal chemokine level / MGI
  • abnormal interleukin level / MGI
  • abnormal tumor necrosis factor level / MGI
  • increased physiological sensitivity to xenobiotic / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • abnormal xenobiotic pharmacokinetics / MGI
  • abnormal liver sinusoid morphology / MGI
  • abnormal sperm head morphology / MGI
  • coiled sperm flagellum / MGI
  • abnormal primordial ovarian follicle morphology / MGI
  • increased urinary bladder carcinoma incidence / MGI
  • hypergranulosis / MGI
  • abnormal optokinetic reflex / MGI
  • urinary bladder inflammation / MGI
  • decreased fertilization frequency / MGI
  • abnormal superovulation / MGI
  • small prostate gland dorsolateral lobe / MGI
  • increased sensitivity to xenobiotic induced morbidity/mortality / MGI
  • decreased sensitivity to xenobiotic induced morbidity/mortality / MGI
  • increased urine uric acid level / MGI
  • increased hepatoma incidence / MGI
  • abnormal stomach pyloric region morphology / MGI
  • pulmonary alveolar edema / MGI
  • abnormal horizontal vestibuloocular reflex / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • cystolithiasis / MGI
  • abnormal seminiferous tubule epithelium morphology / MGI
  • urinary bladder fibrosis / MGI
  • abnormal urinary bladder blood vessel morphology / MGI
  • persistent hyaloid artery / MGI
  • multinucleated giant male germ cells / MGI
  • dilated piliary canal / MGI

Literature references

  • Transgenic mouse lines expressing rat AH receptor variants--a new animal model for research on AH receptor function and dioxin toxicity mechanisms.;Pohjanvirta Raimo, ;2009;Toxicology and applied pharmacology;236;166-82; 19371626

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).